{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:16:05Z","timestamp":1781482565237,"version":"3.54.1"},"reference-count":50,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T00:00:00Z","timestamp":1538697600000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Clinical Hypertension"],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:p>A quantitative survey was completed by 103 primary care physicians (PCPs) and 59 cardiologists who regularly prescribed \u03b2\u2010blockers to assess knowledge and use of this heterogeneous drug class for hypertension. More cardiologists than PCPs chose \u03b2\u2010blockers as initial antihypertensive therapy (30% vs 17%, <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.01). Metoprolol and carvedilol were the most commonly prescribed \u03b2\u2010blockers. Cardiologists rated \u201cimpact on energy\u201d and \u201carterial vasodilation\u201d as more important than PCPs (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.05\/&lt;0.01, respectively). Awareness of vasodilation was greater for carvedilol (52%) than nebivolol (31%). Association between \u03b2\u2010blockers and clinical variables included nebivolol with \u03b2<jats:sub>1<\/jats:sub>\u2010selectivity, nebivolol and carvedilol with vasodilation and efficacy in older patients and African Americans, metoprolol with heart rate reduction, and atenolol and metoprolol with weight gain and hyperglycemia. Physicians preferred prescribing \u03b2\u2010blockers with lower risk of incident diabetes. Clinical practice guidelines influenced physician prescribing more than formularies or performance metrics. This survey captures physicians\u2019 perceptions\/use of various \u03b2\u2010blockers and clinically relevant knowledge gaps.<\/jats:p>","DOI":"10.1111\/jch.13375","type":"journal-article","created":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T09:35:09Z","timestamp":1538818509000},"page":"1464-1472","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Insights on \u03b2\u2010blockers for the treatment of hypertension: A survey of health care practitioners"],"prefix":"10.1111","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1470-5875","authenticated-orcid":false,"given":"Brent","family":"Egan","sequence":"first","affiliation":[{"name":"University of South Carolina School of Medicine\u2010Greenville Greenville South Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Flack","sequence":"additional","affiliation":[{"name":"Department of Medicine Southern Illinois University School of Medicine Springfield Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehul","family":"Patel","sequence":"additional","affiliation":[{"name":"Allergan plc Madison New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Lombera","sequence":"additional","affiliation":[{"name":"McCann Health  London UK (formerly Double Helix)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,10,5]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.8.923"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03530440037034"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000173433.67426.9b"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.03.023"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000485"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000066"},{"key":"e_1_2_9_8_1","volume-title":"Hypertension Prevalence and Control Among Adults: United States, 2015\u20132016. NCHS data brief, no 289","author":"Fryar C","year":"2017"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-017-0728-z"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67185-1"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08089-3"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67573-3"},{"key":"e_1_2_9_13_1","first-page":"Cd002003","article-title":"Beta\u2010blockers for hypertension","volume":"1","author":"Wiysonge CS","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1M381"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2013.12.001"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.12396"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jash.2016.11.007"},{"key":"e_1_2_9_18_1","first-page":"307","article-title":"Use of carvedilol in hypertension: an update","volume":"8","author":"Leonetti G","year":"2012","journal-title":"Vasc Health Risk Manag"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-017-0716-3"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-015-0435-5"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.18.2227"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2009.01.1951"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2012.668495"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/1755-5922.12197"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(17)35080-5"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jash.2010.02.005"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2008.09.038"},{"key":"e_1_2_9_28_1","unstructured":"Market Research Society: Code of Conduct. [website].2014.https:\/\/www.mrs.org.uk\/pdf\/mrs%20code%20of%20conduct%202014.pdf. Accessed August 21 2017."},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2012.03.2532"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2006.10.017"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007990903533681"},{"key":"e_1_2_9_32_1","unstructured":"Office of Disease Prevention and Health Promotion.2020 Topics & Objectives\u2010 Heart Disease and Stroke.2014;https:\/\/www.healthypeople.gov\/2020\/topics-objectives\/topic\/Heart-Disease-and-Stroke\/objectives#4547. Accessed October 18 2017."},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.3.351"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.37.2.250"},{"key":"e_1_2_9_35_1","unstructured":"FlackJ MallickM PatelP.The effects of nebivolol on weight in individuals with hypertension. Poster #61.American Society of Consultant Pharmacists. Kissimmee FL:2017."},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.189589"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(99)00005-9"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.06.048"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.03.610"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1000571"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.6.825"},{"issue":"8","key":"e_1_2_9_42_1","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/archinte.1990.00040031707020","article-title":"A comparison of the efficacy and safety of a beta\u2010blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks","volume":"150","author":"Saunders E","year":"1990","journal-title":"Arch Intern Med"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2007.07548.x"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7176.2009.00119.x"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2010.04.015"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e318277d6a0"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.05.019"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0b013e31819fd501"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31822b007a"},{"key":"e_1_2_9_50_1","first-page":"Cd007449","article-title":"Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension","volume":"8","author":"Wong GW","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_9_51_1","first-page":"Cd007451","article-title":"Blood pressure lowering efficacy of beta\u20101 selective beta blockers for primary hypertension","volume":"3","author":"Wong GW","year":"2016","journal-title":"Cochrane Database Syst Rev"}],"container-title":["The Journal of Clinical Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjch.13375","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jch.13375","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T07:13:22Z","timestamp":1694934802000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jch.13375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["10.1111\/jch.13375"],"URL":"https:\/\/doi.org\/10.1111\/jch.13375","archive":["Portico"],"relation":{},"ISSN":["1524-6175","1751-7176"],"issn-type":[{"value":"1524-6175","type":"print"},{"value":"1751-7176","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"2018-03-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}